Global Antiviral Medications for Seasonal Influenza Market Research Report 2026(Status and Outlook)
Seasonal influenza antiviral drugs are a class of drugs specifically used to prevent and treat seasonal influenza caused by influenza viruses. These drugs work by directly acting on the virus or inhibiting its replication process, thereby alleviating symptoms, shortening the course of the disease, and reducing the risk of complications. Common antiviral drugs include neuraminidase inhibitors and M2 ion channel inhibitors.
The global Antiviral Medications for Seasonal Influenza market size was estimated at USD 921.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Antiviral Medications for Seasonal Influenza market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Antiviral Medications for Seasonal Influenza market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Antiviral Medications for Seasonal Influenza market.
Global Antiviral Medications for Seasonal Influenza Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Roche
HEC Pharma
Qilu Pharmaceutical
CSPC
Kelun
Market Segmentation (by Type)
Baloxavir marboxil
Oseltamivir
Zanamivir
Peramivir
Market Segmentation (by Application)
Influenza A
Influenza B
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Antiviral Medications for Seasonal Influenza Market
Overview of the regional outlook of the Antiviral Medications for Seasonal Influenza Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antiviral Medications for Seasonal Influenza Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Antiviral Medications for Seasonal Influenza, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Antiviral Medications for Seasonal Influenza market size was estimated at USD 921.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Antiviral Medications for Seasonal Influenza market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Antiviral Medications for Seasonal Influenza market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Antiviral Medications for Seasonal Influenza market.
Global Antiviral Medications for Seasonal Influenza Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Roche
HEC Pharma
Qilu Pharmaceutical
CSPC
Kelun
Market Segmentation (by Type)
Baloxavir marboxil
Oseltamivir
Zanamivir
Peramivir
Market Segmentation (by Application)
Influenza A
Influenza B
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Antiviral Medications for Seasonal Influenza Market
Overview of the regional outlook of the Antiviral Medications for Seasonal Influenza Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antiviral Medications for Seasonal Influenza Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Antiviral Medications for Seasonal Influenza, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Antiviral Medications for Seasonal Influenza
1.2 Key Market Segments
1.2.1 Antiviral Medications for Seasonal Influenza Segment by Type
1.2.2 Antiviral Medications for Seasonal Influenza Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTIVIRAL MEDICATIONS FOR SEASONAL INFLUENZA MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Antiviral Medications for Seasonal Influenza Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Antiviral Medications for Seasonal Influenza Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTIVIRAL MEDICATIONS FOR SEASONAL INFLUENZA MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Antiviral Medications for Seasonal Influenza Product Life Cycle
3.3 Global Antiviral Medications for Seasonal Influenza Sales by Manufacturers (2020-2025)
3.4 Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Manufacturers (2020-2025)
3.5 Antiviral Medications for Seasonal Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Antiviral Medications for Seasonal Influenza Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Antiviral Medications for Seasonal Influenza Market Competitive Situation and Trends
3.8.1 Antiviral Medications for Seasonal Influenza Market Concentration Rate
3.8.2 Global 5 and 10 Largest Antiviral Medications for Seasonal Influenza Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ANTIVIRAL MEDICATIONS FOR SEASONAL INFLUENZA INDUSTRY CHAIN ANALYSIS
4.1 Antiviral Medications for Seasonal Influenza Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTIVIRAL MEDICATIONS FOR SEASONAL INFLUENZA MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Antiviral Medications for Seasonal Influenza Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Antiviral Medications for Seasonal Influenza Market
5.7 ESG Ratings of Leading Companies
6 ANTIVIRAL MEDICATIONS FOR SEASONAL INFLUENZA MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antiviral Medications for Seasonal Influenza Sales Market Share by Type (2020-2025)
6.3 Global Antiviral Medications for Seasonal Influenza Market Size by Type (2020-2025)
6.4 Global Antiviral Medications for Seasonal Influenza Price by Type (2020-2025)
7 ANTIVIRAL MEDICATIONS FOR SEASONAL INFLUENZA MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antiviral Medications for Seasonal Influenza Market Sales by Application (2020-2025)
7.3 Global Antiviral Medications for Seasonal Influenza Market Size (M USD) by Application (2020-2025)
7.4 Global Antiviral Medications for Seasonal Influenza Sales Growth Rate by Application (2020-2025)
8 ANTIVIRAL MEDICATIONS FOR SEASONAL INFLUENZA MARKET SALES BY REGION
8.1 Global Antiviral Medications for Seasonal Influenza Sales by Region
8.1.1 Global Antiviral Medications for Seasonal Influenza Sales by Region
8.1.2 Global Antiviral Medications for Seasonal Influenza Sales Market Share by Region
8.2 Global Antiviral Medications for Seasonal Influenza Market Size by Region
8.2.1 Global Antiviral Medications for Seasonal Influenza Market Size by Region
8.2.2 Global Antiviral Medications for Seasonal Influenza Market Size by Region
8.3 North America
8.3.1 North America Antiviral Medications for Seasonal Influenza Sales by Country
8.3.2 North America Antiviral Medications for Seasonal Influenza Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Antiviral Medications for Seasonal Influenza Sales by Country
8.4.2 Europe Antiviral Medications for Seasonal Influenza Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Antiviral Medications for Seasonal Influenza Sales by Region
8.5.2 Asia Pacific Antiviral Medications for Seasonal Influenza Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Antiviral Medications for Seasonal Influenza Sales by Country
8.6.2 South America Antiviral Medications for Seasonal Influenza Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Antiviral Medications for Seasonal Influenza Sales by Region
8.7.2 Middle East and Africa Antiviral Medications for Seasonal Influenza Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ANTIVIRAL MEDICATIONS FOR SEASONAL INFLUENZA MARKET PRODUCTION BY REGION
9.1 Global Production of Antiviral Medications for Seasonal Influenza by Region(2020-2025)
9.2 Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Region (2020-2025)
9.3 Global Antiviral Medications for Seasonal Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Antiviral Medications for Seasonal Influenza Production
9.4.1 North America Antiviral Medications for Seasonal Influenza Production Growth Rate (2020-2025)
9.4.2 North America Antiviral Medications for Seasonal Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Antiviral Medications for Seasonal Influenza Production
9.5.1 Europe Antiviral Medications for Seasonal Influenza Production Growth Rate (2020-2025)
9.5.2 Europe Antiviral Medications for Seasonal Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Antiviral Medications for Seasonal Influenza Production (2020-2025)
9.6.1 Japan Antiviral Medications for Seasonal Influenza Production Growth Rate (2020-2025)
9.6.2 Japan Antiviral Medications for Seasonal Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Antiviral Medications for Seasonal Influenza Production (2020-2025)
9.7.1 China Antiviral Medications for Seasonal Influenza Production Growth Rate (2020-2025)
9.7.2 China Antiviral Medications for Seasonal Influenza Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Roche
10.1.1 Roche Basic Information
10.1.2 Roche Antiviral Medications for Seasonal Influenza Product Overview
10.1.3 Roche Antiviral Medications for Seasonal Influenza Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche SWOT Analysis
10.1.6 Roche Recent Developments
10.2 HEC Pharma
10.2.1 HEC Pharma Basic Information
10.2.2 HEC Pharma Antiviral Medications for Seasonal Influenza Product Overview
10.2.3 HEC Pharma Antiviral Medications for Seasonal Influenza Product Market Performance
10.2.4 HEC Pharma Business Overview
10.2.5 HEC Pharma SWOT Analysis
10.2.6 HEC Pharma Recent Developments
10.3 Qilu Pharmaceutical
10.3.1 Qilu Pharmaceutical Basic Information
10.3.2 Qilu Pharmaceutical Antiviral Medications for Seasonal Influenza Product Overview
10.3.3 Qilu Pharmaceutical Antiviral Medications for Seasonal Influenza Product Market Performance
10.3.4 Qilu Pharmaceutical Business Overview
10.3.5 Qilu Pharmaceutical SWOT Analysis
10.3.6 Qilu Pharmaceutical Recent Developments
10.4 CSPC
10.4.1 CSPC Basic Information
10.4.2 CSPC Antiviral Medications for Seasonal Influenza Product Overview
10.4.3 CSPC Antiviral Medications for Seasonal Influenza Product Market Performance
10.4.4 CSPC Business Overview
10.4.5 CSPC Recent Developments
10.5 Kelun
10.5.1 Kelun Basic Information
10.5.2 Kelun Antiviral Medications for Seasonal Influenza Product Overview
10.5.3 Kelun Antiviral Medications for Seasonal Influenza Product Market Performance
10.5.4 Kelun Business Overview
10.5.5 Kelun Recent Developments
11 ANTIVIRAL MEDICATIONS FOR SEASONAL INFLUENZA MARKET FORECAST BY REGION
11.1 Global Antiviral Medications for Seasonal Influenza Market Size Forecast
11.2 Global Antiviral Medications for Seasonal Influenza Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Antiviral Medications for Seasonal Influenza Market Size Forecast by Country
11.2.3 Asia Pacific Antiviral Medications for Seasonal Influenza Market Size Forecast by Region
11.2.4 South America Antiviral Medications for Seasonal Influenza Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Antiviral Medications for Seasonal Influenza by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Antiviral Medications for Seasonal Influenza Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Antiviral Medications for Seasonal Influenza by Type (2026-2035)
12.1.2 Global Antiviral Medications for Seasonal Influenza Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Antiviral Medications for Seasonal Influenza by Type (2026-2035)
12.2 Global Antiviral Medications for Seasonal Influenza Market Forecast by Application (2026-2035)
12.2.1 Global Antiviral Medications for Seasonal Influenza Sales (K MT) Forecast by Application
12.2.2 Global Antiviral Medications for Seasonal Influenza Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Antiviral Medications for Seasonal Influenza
1.2 Key Market Segments
1.2.1 Antiviral Medications for Seasonal Influenza Segment by Type
1.2.2 Antiviral Medications for Seasonal Influenza Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTIVIRAL MEDICATIONS FOR SEASONAL INFLUENZA MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Antiviral Medications for Seasonal Influenza Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Antiviral Medications for Seasonal Influenza Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTIVIRAL MEDICATIONS FOR SEASONAL INFLUENZA MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Antiviral Medications for Seasonal Influenza Product Life Cycle
3.3 Global Antiviral Medications for Seasonal Influenza Sales by Manufacturers (2020-2025)
3.4 Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Manufacturers (2020-2025)
3.5 Antiviral Medications for Seasonal Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Antiviral Medications for Seasonal Influenza Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Antiviral Medications for Seasonal Influenza Market Competitive Situation and Trends
3.8.1 Antiviral Medications for Seasonal Influenza Market Concentration Rate
3.8.2 Global 5 and 10 Largest Antiviral Medications for Seasonal Influenza Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ANTIVIRAL MEDICATIONS FOR SEASONAL INFLUENZA INDUSTRY CHAIN ANALYSIS
4.1 Antiviral Medications for Seasonal Influenza Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTIVIRAL MEDICATIONS FOR SEASONAL INFLUENZA MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Antiviral Medications for Seasonal Influenza Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Antiviral Medications for Seasonal Influenza Market
5.7 ESG Ratings of Leading Companies
6 ANTIVIRAL MEDICATIONS FOR SEASONAL INFLUENZA MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antiviral Medications for Seasonal Influenza Sales Market Share by Type (2020-2025)
6.3 Global Antiviral Medications for Seasonal Influenza Market Size by Type (2020-2025)
6.4 Global Antiviral Medications for Seasonal Influenza Price by Type (2020-2025)
7 ANTIVIRAL MEDICATIONS FOR SEASONAL INFLUENZA MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antiviral Medications for Seasonal Influenza Market Sales by Application (2020-2025)
7.3 Global Antiviral Medications for Seasonal Influenza Market Size (M USD) by Application (2020-2025)
7.4 Global Antiviral Medications for Seasonal Influenza Sales Growth Rate by Application (2020-2025)
8 ANTIVIRAL MEDICATIONS FOR SEASONAL INFLUENZA MARKET SALES BY REGION
8.1 Global Antiviral Medications for Seasonal Influenza Sales by Region
8.1.1 Global Antiviral Medications for Seasonal Influenza Sales by Region
8.1.2 Global Antiviral Medications for Seasonal Influenza Sales Market Share by Region
8.2 Global Antiviral Medications for Seasonal Influenza Market Size by Region
8.2.1 Global Antiviral Medications for Seasonal Influenza Market Size by Region
8.2.2 Global Antiviral Medications for Seasonal Influenza Market Size by Region
8.3 North America
8.3.1 North America Antiviral Medications for Seasonal Influenza Sales by Country
8.3.2 North America Antiviral Medications for Seasonal Influenza Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Antiviral Medications for Seasonal Influenza Sales by Country
8.4.2 Europe Antiviral Medications for Seasonal Influenza Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Antiviral Medications for Seasonal Influenza Sales by Region
8.5.2 Asia Pacific Antiviral Medications for Seasonal Influenza Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Antiviral Medications for Seasonal Influenza Sales by Country
8.6.2 South America Antiviral Medications for Seasonal Influenza Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Antiviral Medications for Seasonal Influenza Sales by Region
8.7.2 Middle East and Africa Antiviral Medications for Seasonal Influenza Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ANTIVIRAL MEDICATIONS FOR SEASONAL INFLUENZA MARKET PRODUCTION BY REGION
9.1 Global Production of Antiviral Medications for Seasonal Influenza by Region(2020-2025)
9.2 Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Region (2020-2025)
9.3 Global Antiviral Medications for Seasonal Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Antiviral Medications for Seasonal Influenza Production
9.4.1 North America Antiviral Medications for Seasonal Influenza Production Growth Rate (2020-2025)
9.4.2 North America Antiviral Medications for Seasonal Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Antiviral Medications for Seasonal Influenza Production
9.5.1 Europe Antiviral Medications for Seasonal Influenza Production Growth Rate (2020-2025)
9.5.2 Europe Antiviral Medications for Seasonal Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Antiviral Medications for Seasonal Influenza Production (2020-2025)
9.6.1 Japan Antiviral Medications for Seasonal Influenza Production Growth Rate (2020-2025)
9.6.2 Japan Antiviral Medications for Seasonal Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Antiviral Medications for Seasonal Influenza Production (2020-2025)
9.7.1 China Antiviral Medications for Seasonal Influenza Production Growth Rate (2020-2025)
9.7.2 China Antiviral Medications for Seasonal Influenza Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Roche
10.1.1 Roche Basic Information
10.1.2 Roche Antiviral Medications for Seasonal Influenza Product Overview
10.1.3 Roche Antiviral Medications for Seasonal Influenza Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche SWOT Analysis
10.1.6 Roche Recent Developments
10.2 HEC Pharma
10.2.1 HEC Pharma Basic Information
10.2.2 HEC Pharma Antiviral Medications for Seasonal Influenza Product Overview
10.2.3 HEC Pharma Antiviral Medications for Seasonal Influenza Product Market Performance
10.2.4 HEC Pharma Business Overview
10.2.5 HEC Pharma SWOT Analysis
10.2.6 HEC Pharma Recent Developments
10.3 Qilu Pharmaceutical
10.3.1 Qilu Pharmaceutical Basic Information
10.3.2 Qilu Pharmaceutical Antiviral Medications for Seasonal Influenza Product Overview
10.3.3 Qilu Pharmaceutical Antiviral Medications for Seasonal Influenza Product Market Performance
10.3.4 Qilu Pharmaceutical Business Overview
10.3.5 Qilu Pharmaceutical SWOT Analysis
10.3.6 Qilu Pharmaceutical Recent Developments
10.4 CSPC
10.4.1 CSPC Basic Information
10.4.2 CSPC Antiviral Medications for Seasonal Influenza Product Overview
10.4.3 CSPC Antiviral Medications for Seasonal Influenza Product Market Performance
10.4.4 CSPC Business Overview
10.4.5 CSPC Recent Developments
10.5 Kelun
10.5.1 Kelun Basic Information
10.5.2 Kelun Antiviral Medications for Seasonal Influenza Product Overview
10.5.3 Kelun Antiviral Medications for Seasonal Influenza Product Market Performance
10.5.4 Kelun Business Overview
10.5.5 Kelun Recent Developments
11 ANTIVIRAL MEDICATIONS FOR SEASONAL INFLUENZA MARKET FORECAST BY REGION
11.1 Global Antiviral Medications for Seasonal Influenza Market Size Forecast
11.2 Global Antiviral Medications for Seasonal Influenza Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Antiviral Medications for Seasonal Influenza Market Size Forecast by Country
11.2.3 Asia Pacific Antiviral Medications for Seasonal Influenza Market Size Forecast by Region
11.2.4 South America Antiviral Medications for Seasonal Influenza Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Antiviral Medications for Seasonal Influenza by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Antiviral Medications for Seasonal Influenza Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Antiviral Medications for Seasonal Influenza by Type (2026-2035)
12.1.2 Global Antiviral Medications for Seasonal Influenza Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Antiviral Medications for Seasonal Influenza by Type (2026-2035)
12.2 Global Antiviral Medications for Seasonal Influenza Market Forecast by Application (2026-2035)
12.2.1 Global Antiviral Medications for Seasonal Influenza Sales (K MT) Forecast by Application
12.2.2 Global Antiviral Medications for Seasonal Influenza Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Antiviral Medications for Seasonal Influenza Market Size by Type (M USD)
Table 4. Global Antiviral Medications for Seasonal Influenza Market Size by Application
Table 5. Antiviral Medications for Seasonal Influenza Market Size Comparison by Region (M USD)
Table 6. Global Antiviral Medications for Seasonal Influenza Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Antiviral Medications for Seasonal Influenza Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Antiviral Medications for Seasonal Influenza Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Medications for Seasonal Influenza as of 2025)
Table 11. Global Market Antiviral Medications for Seasonal Influenza Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Antiviral Medications for Seasonal Influenza Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antiviral Medications for Seasonal Influenza Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Antiviral Medications for Seasonal Influenza Sales by Type (K MT)
Table 27. Global Antiviral Medications for Seasonal Influenza Market Size by Type (M USD)
Table 28. Global Antiviral Medications for Seasonal Influenza Sales (K MT) by Type (2020-2025)
Table 29. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Type (2020-2025)
Table 30. Global Antiviral Medications for Seasonal Influenza Market Size (M USD) by Type (2020-2025)
Table 31. Global Antiviral Medications for Seasonal Influenza Market Share by Type (2020-2025)
Table 32. Global Antiviral Medications for Seasonal Influenza Price (USD/KG) by Type (2020-2025)
Table 33. Global Antiviral Medications for Seasonal Influenza Sales (K MT) by Application
Table 34. Global Antiviral Medications for Seasonal Influenza Market Size by Application
Table 35. Global Antiviral Medications for Seasonal Influenza Sales by Application (2020-2025) & (K MT)
Table 36. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Application (2020-2025)
Table 37. Global Antiviral Medications for Seasonal Influenza Market Size by Application (2020-2025) & (M USD)
Table 38. Global Antiviral Medications for Seasonal Influenza Market Share by Application (2020-2025)
Table 39. Global Antiviral Medications for Seasonal Influenza Sales Growth Rate by Application (2020-2025)
Table 40. Global Antiviral Medications for Seasonal Influenza Sales by Region (2020-2025) & (K MT)
Table 41. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Region (2020-2025)
Table 42. Global Antiviral Medications for Seasonal Influenza Market Size by Region (2020-2025) & (M USD)
Table 43. Global Antiviral Medications for Seasonal Influenza Market Size by Region (2020-2025)
Table 44. North America Antiviral Medications for Seasonal Influenza Sales by Country (2020-2025) & (K MT)
Table 45. North America Antiviral Medications for Seasonal Influenza Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Antiviral Medications for Seasonal Influenza Sales by Country (2020-2025) & (K MT)
Table 47. Europe Antiviral Medications for Seasonal Influenza Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Antiviral Medications for Seasonal Influenza Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Antiviral Medications for Seasonal Influenza Market Size by Region (2020-2025) & (M USD)
Table 50. South America Antiviral Medications for Seasonal Influenza Sales by Country (2020-2025) & (K MT)
Table 51. South America Antiviral Medications for Seasonal Influenza Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Antiviral Medications for Seasonal Influenza Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Antiviral Medications for Seasonal Influenza Market Size by Region (2020-2025) & (M USD)
Table 54. Global Antiviral Medications for Seasonal Influenza Production (K MT) by Region(2020-2025)
Table 55. Global Antiviral Medications for Seasonal Influenza Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Region (2020-2025)
Table 57. Global Antiviral Medications for Seasonal Influenza Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Antiviral Medications for Seasonal Influenza Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Antiviral Medications for Seasonal Influenza Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Antiviral Medications for Seasonal Influenza Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Antiviral Medications for Seasonal Influenza Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Roche Basic Information
Table 63. Roche Antiviral Medications for Seasonal Influenza Product Overview
Table 64. Roche Antiviral Medications for Seasonal Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Roche Business Overview
Table 66. Roche SWOT Analysis
Table 67. Roche Recent Developments
Table 68. HEC Pharma Basic Information
Table 69. HEC Pharma Antiviral Medications for Seasonal Influenza Product Overview
Table 70. HEC Pharma Antiviral Medications for Seasonal Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. HEC Pharma Business Overview
Table 72. HEC Pharma SWOT Analysis
Table 73. HEC Pharma Recent Developments
Table 74. Qilu Pharmaceutical Basic Information
Table 75. Qilu Pharmaceutical Antiviral Medications for Seasonal Influenza Product Overview
Table 76. Qilu Pharmaceutical Antiviral Medications for Seasonal Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Qilu Pharmaceutical Business Overview
Table 78. Qilu Pharmaceutical SWOT Analysis
Table 79. Qilu Pharmaceutical Recent Developments
Table 80. CSPC Basic Information
Table 81. CSPC Antiviral Medications for Seasonal Influenza Product Overview
Table 82. CSPC Antiviral Medications for Seasonal Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. CSPC Business Overview
Table 84. CSPC Recent Developments
Table 85. Kelun Basic Information
Table 86. Kelun Antiviral Medications for Seasonal Influenza Product Overview
Table 87. Kelun Antiviral Medications for Seasonal Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Kelun Business Overview
Table 89. Kelun Recent Developments
Table 90. Global Antiviral Medications for Seasonal Influenza Sales Forecast by Region (2026-2035) & (K MT)
Table 91. Global Antiviral Medications for Seasonal Influenza Market Size Forecast by Region (2026-2035) & (M USD)
Table 92. North America Antiviral Medications for Seasonal Influenza Sales Forecast by Country (2026-2035) & (K MT)
Table 93. North America Antiviral Medications for Seasonal Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 94. Europe Antiviral Medications for Seasonal Influenza Sales Forecast by Country (2026-2035) & (K MT)
Table 95. Europe Antiviral Medications for Seasonal Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 96. Asia Pacific Antiviral Medications for Seasonal Influenza Sales Forecast by Region (2026-2035) & (K MT)
Table 97. Asia Pacific Antiviral Medications for Seasonal Influenza Market Size Forecast by Region (2026-2035) & (M USD)
Table 98. South America Antiviral Medications for Seasonal Influenza Sales Forecast by Country (2026-2035) & (K MT)
Table 99. South America Antiviral Medications for Seasonal Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 100. Middle East and Africa Antiviral Medications for Seasonal Influenza Sales Forecast by Country (2026-2035) & (Units)
Table 101. Middle East and Africa Antiviral Medications for Seasonal Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 102. Global Antiviral Medications for Seasonal Influenza Sales Forecast by Type (2026-2035) & (K MT)
Table 103. Global Antiviral Medications for Seasonal Influenza Market Size Forecast by Type (2026-2035) & (M USD)
Table 104. Global Antiviral Medications for Seasonal Influenza Price Forecast by Type (2026-2035) & (USD/KG)
Table 105. Global Antiviral Medications for Seasonal Influenza Sales (K MT) Forecast by Application (2026-2035)
Table 106. Global Antiviral Medications for Seasonal Influenza Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Antiviral Medications for Seasonal Influenza Market Size by Type (M USD)
Table 4. Global Antiviral Medications for Seasonal Influenza Market Size by Application
Table 5. Antiviral Medications for Seasonal Influenza Market Size Comparison by Region (M USD)
Table 6. Global Antiviral Medications for Seasonal Influenza Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Antiviral Medications for Seasonal Influenza Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Antiviral Medications for Seasonal Influenza Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Medications for Seasonal Influenza as of 2025)
Table 11. Global Market Antiviral Medications for Seasonal Influenza Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Antiviral Medications for Seasonal Influenza Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antiviral Medications for Seasonal Influenza Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Antiviral Medications for Seasonal Influenza Sales by Type (K MT)
Table 27. Global Antiviral Medications for Seasonal Influenza Market Size by Type (M USD)
Table 28. Global Antiviral Medications for Seasonal Influenza Sales (K MT) by Type (2020-2025)
Table 29. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Type (2020-2025)
Table 30. Global Antiviral Medications for Seasonal Influenza Market Size (M USD) by Type (2020-2025)
Table 31. Global Antiviral Medications for Seasonal Influenza Market Share by Type (2020-2025)
Table 32. Global Antiviral Medications for Seasonal Influenza Price (USD/KG) by Type (2020-2025)
Table 33. Global Antiviral Medications for Seasonal Influenza Sales (K MT) by Application
Table 34. Global Antiviral Medications for Seasonal Influenza Market Size by Application
Table 35. Global Antiviral Medications for Seasonal Influenza Sales by Application (2020-2025) & (K MT)
Table 36. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Application (2020-2025)
Table 37. Global Antiviral Medications for Seasonal Influenza Market Size by Application (2020-2025) & (M USD)
Table 38. Global Antiviral Medications for Seasonal Influenza Market Share by Application (2020-2025)
Table 39. Global Antiviral Medications for Seasonal Influenza Sales Growth Rate by Application (2020-2025)
Table 40. Global Antiviral Medications for Seasonal Influenza Sales by Region (2020-2025) & (K MT)
Table 41. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Region (2020-2025)
Table 42. Global Antiviral Medications for Seasonal Influenza Market Size by Region (2020-2025) & (M USD)
Table 43. Global Antiviral Medications for Seasonal Influenza Market Size by Region (2020-2025)
Table 44. North America Antiviral Medications for Seasonal Influenza Sales by Country (2020-2025) & (K MT)
Table 45. North America Antiviral Medications for Seasonal Influenza Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Antiviral Medications for Seasonal Influenza Sales by Country (2020-2025) & (K MT)
Table 47. Europe Antiviral Medications for Seasonal Influenza Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Antiviral Medications for Seasonal Influenza Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Antiviral Medications for Seasonal Influenza Market Size by Region (2020-2025) & (M USD)
Table 50. South America Antiviral Medications for Seasonal Influenza Sales by Country (2020-2025) & (K MT)
Table 51. South America Antiviral Medications for Seasonal Influenza Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Antiviral Medications for Seasonal Influenza Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Antiviral Medications for Seasonal Influenza Market Size by Region (2020-2025) & (M USD)
Table 54. Global Antiviral Medications for Seasonal Influenza Production (K MT) by Region(2020-2025)
Table 55. Global Antiviral Medications for Seasonal Influenza Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Antiviral Medications for Seasonal Influenza Revenue Market Share by Region (2020-2025)
Table 57. Global Antiviral Medications for Seasonal Influenza Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Antiviral Medications for Seasonal Influenza Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Antiviral Medications for Seasonal Influenza Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Antiviral Medications for Seasonal Influenza Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Antiviral Medications for Seasonal Influenza Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Roche Basic Information
Table 63. Roche Antiviral Medications for Seasonal Influenza Product Overview
Table 64. Roche Antiviral Medications for Seasonal Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Roche Business Overview
Table 66. Roche SWOT Analysis
Table 67. Roche Recent Developments
Table 68. HEC Pharma Basic Information
Table 69. HEC Pharma Antiviral Medications for Seasonal Influenza Product Overview
Table 70. HEC Pharma Antiviral Medications for Seasonal Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. HEC Pharma Business Overview
Table 72. HEC Pharma SWOT Analysis
Table 73. HEC Pharma Recent Developments
Table 74. Qilu Pharmaceutical Basic Information
Table 75. Qilu Pharmaceutical Antiviral Medications for Seasonal Influenza Product Overview
Table 76. Qilu Pharmaceutical Antiviral Medications for Seasonal Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Qilu Pharmaceutical Business Overview
Table 78. Qilu Pharmaceutical SWOT Analysis
Table 79. Qilu Pharmaceutical Recent Developments
Table 80. CSPC Basic Information
Table 81. CSPC Antiviral Medications for Seasonal Influenza Product Overview
Table 82. CSPC Antiviral Medications for Seasonal Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. CSPC Business Overview
Table 84. CSPC Recent Developments
Table 85. Kelun Basic Information
Table 86. Kelun Antiviral Medications for Seasonal Influenza Product Overview
Table 87. Kelun Antiviral Medications for Seasonal Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Kelun Business Overview
Table 89. Kelun Recent Developments
Table 90. Global Antiviral Medications for Seasonal Influenza Sales Forecast by Region (2026-2035) & (K MT)
Table 91. Global Antiviral Medications for Seasonal Influenza Market Size Forecast by Region (2026-2035) & (M USD)
Table 92. North America Antiviral Medications for Seasonal Influenza Sales Forecast by Country (2026-2035) & (K MT)
Table 93. North America Antiviral Medications for Seasonal Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 94. Europe Antiviral Medications for Seasonal Influenza Sales Forecast by Country (2026-2035) & (K MT)
Table 95. Europe Antiviral Medications for Seasonal Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 96. Asia Pacific Antiviral Medications for Seasonal Influenza Sales Forecast by Region (2026-2035) & (K MT)
Table 97. Asia Pacific Antiviral Medications for Seasonal Influenza Market Size Forecast by Region (2026-2035) & (M USD)
Table 98. South America Antiviral Medications for Seasonal Influenza Sales Forecast by Country (2026-2035) & (K MT)
Table 99. South America Antiviral Medications for Seasonal Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 100. Middle East and Africa Antiviral Medications for Seasonal Influenza Sales Forecast by Country (2026-2035) & (Units)
Table 101. Middle East and Africa Antiviral Medications for Seasonal Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 102. Global Antiviral Medications for Seasonal Influenza Sales Forecast by Type (2026-2035) & (K MT)
Table 103. Global Antiviral Medications for Seasonal Influenza Market Size Forecast by Type (2026-2035) & (M USD)
Table 104. Global Antiviral Medications for Seasonal Influenza Price Forecast by Type (2026-2035) & (USD/KG)
Table 105. Global Antiviral Medications for Seasonal Influenza Sales (K MT) Forecast by Application (2026-2035)
Table 106. Global Antiviral Medications for Seasonal Influenza Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Antiviral Medications for Seasonal Influenza
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antiviral Medications for Seasonal Influenza Market Size (M USD), 2025-2035
Figure 5. Global Antiviral Medications for Seasonal Influenza Market Size (M USD) (2020-2035)
Figure 6. Global Antiviral Medications for Seasonal Influenza Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antiviral Medications for Seasonal Influenza Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Antiviral Medications for Seasonal Influenza Product Life Cycle
Figure 13. Antiviral Medications for Seasonal Influenza Sales Share by Manufacturers in 2025
Figure 14. Global Antiviral Medications for Seasonal Influenza Revenue Share by Manufacturers in 2025
Figure 15. Antiviral Medications for Seasonal Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Antiviral Medications for Seasonal Influenza Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Antiviral Medications for Seasonal Influenza Revenue in 2025
Figure 18. Industry Chain Map of Antiviral Medications for Seasonal Influenza
Figure 19. Global Antiviral Medications for Seasonal Influenza Market PEST Analysis
Figure 20. Global Antiviral Medications for Seasonal Influenza Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Antiviral Medications for Seasonal Influenza Market Share by Type
Figure 27. Sales Market Share of Antiviral Medications for Seasonal Influenza by Type (2020-2025)
Figure 28. Sales Market Share of Antiviral Medications for Seasonal Influenza by Type in 2025
Figure 29. Market Share of Antiviral Medications for Seasonal Influenza by Type (2020-2025)
Figure 30. Market Share of Antiviral Medications for Seasonal Influenza by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Antiviral Medications for Seasonal Influenza Market Share by Application
Figure 33. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Application (2020-2025)
Figure 34. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Application in 2025
Figure 35. Global Antiviral Medications for Seasonal Influenza Market Share by Application (2020-2025)
Figure 36. Global Antiviral Medications for Seasonal Influenza Market Share by Application in 2025
Figure 37. Global Antiviral Medications for Seasonal Influenza Sales Growth Rate by Application (2020-2025)
Figure 38. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Region (2020-2025)
Figure 39. Global Antiviral Medications for Seasonal Influenza Market Size by Region (2020-2025)
Figure 40. North America Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Antiviral Medications for Seasonal Influenza Sales Market Share by Country in 2024
Figure 43. North America Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Antiviral Medications for Seasonal Influenza Market Size by Country in 2024
Figure 45. U.S. Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Antiviral Medications for Seasonal Influenza Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Antiviral Medications for Seasonal Influenza Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Antiviral Medications for Seasonal Influenza Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Antiviral Medications for Seasonal Influenza Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Antiviral Medications for Seasonal Influenza Sales Market Share by Country in 2024
Figure 53. Europe Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Antiviral Medications for Seasonal Influenza Market Size by Country in 2024
Figure 55. Germany Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Antiviral Medications for Seasonal Influenza Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Antiviral Medications for Seasonal Influenza Sales Market Share by Region in 2024
Figure 67. Asia Pacific Antiviral Medications for Seasonal Influenza Market Size by Region in 2024
Figure 68. China Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Antiviral Medications for Seasonal Influenza Sales and Growth Rate (K MT)
Figure 79. South America Antiviral Medications for Seasonal Influenza Sales Market Share by Country in 2024
Figure 80. South America Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (M USD)
Figure 81. South America Antiviral Medications for Seasonal Influenza Market Size by Country in 2024
Figure 82. Brazil Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Antiviral Medications for Seasonal Influenza Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Antiviral Medications for Seasonal Influenza Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Antiviral Medications for Seasonal Influenza Market Size by Region in 2024
Figure 92. Saudi Arabia Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Antiviral Medications for Seasonal Influenza Production Market Share by Region (2020-2025)
Figure 103. North America Antiviral Medications for Seasonal Influenza Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Antiviral Medications for Seasonal Influenza Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Antiviral Medications for Seasonal Influenza Production (K MT) Growth Rate (2020-2025)
Figure 106. China Antiviral Medications for Seasonal Influenza Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Antiviral Medications for Seasonal Influenza Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Antiviral Medications for Seasonal Influenza Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Antiviral Medications for Seasonal Influenza Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Antiviral Medications for Seasonal Influenza Market Share Forecast by Type (2026-2035)
Figure 111. Global Antiviral Medications for Seasonal Influenza Sales Forecast by Application (2026-2035)
Figure 112. Global Antiviral Medications for Seasonal Influenza Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Antiviral Medications for Seasonal Influenza
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antiviral Medications for Seasonal Influenza Market Size (M USD), 2025-2035
Figure 5. Global Antiviral Medications for Seasonal Influenza Market Size (M USD) (2020-2035)
Figure 6. Global Antiviral Medications for Seasonal Influenza Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antiviral Medications for Seasonal Influenza Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Antiviral Medications for Seasonal Influenza Product Life Cycle
Figure 13. Antiviral Medications for Seasonal Influenza Sales Share by Manufacturers in 2025
Figure 14. Global Antiviral Medications for Seasonal Influenza Revenue Share by Manufacturers in 2025
Figure 15. Antiviral Medications for Seasonal Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Antiviral Medications for Seasonal Influenza Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Antiviral Medications for Seasonal Influenza Revenue in 2025
Figure 18. Industry Chain Map of Antiviral Medications for Seasonal Influenza
Figure 19. Global Antiviral Medications for Seasonal Influenza Market PEST Analysis
Figure 20. Global Antiviral Medications for Seasonal Influenza Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Antiviral Medications for Seasonal Influenza Market Share by Type
Figure 27. Sales Market Share of Antiviral Medications for Seasonal Influenza by Type (2020-2025)
Figure 28. Sales Market Share of Antiviral Medications for Seasonal Influenza by Type in 2025
Figure 29. Market Share of Antiviral Medications for Seasonal Influenza by Type (2020-2025)
Figure 30. Market Share of Antiviral Medications for Seasonal Influenza by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Antiviral Medications for Seasonal Influenza Market Share by Application
Figure 33. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Application (2020-2025)
Figure 34. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Application in 2025
Figure 35. Global Antiviral Medications for Seasonal Influenza Market Share by Application (2020-2025)
Figure 36. Global Antiviral Medications for Seasonal Influenza Market Share by Application in 2025
Figure 37. Global Antiviral Medications for Seasonal Influenza Sales Growth Rate by Application (2020-2025)
Figure 38. Global Antiviral Medications for Seasonal Influenza Sales Market Share by Region (2020-2025)
Figure 39. Global Antiviral Medications for Seasonal Influenza Market Size by Region (2020-2025)
Figure 40. North America Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Antiviral Medications for Seasonal Influenza Sales Market Share by Country in 2024
Figure 43. North America Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Antiviral Medications for Seasonal Influenza Market Size by Country in 2024
Figure 45. U.S. Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Antiviral Medications for Seasonal Influenza Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Antiviral Medications for Seasonal Influenza Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Antiviral Medications for Seasonal Influenza Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Antiviral Medications for Seasonal Influenza Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Antiviral Medications for Seasonal Influenza Sales Market Share by Country in 2024
Figure 53. Europe Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Antiviral Medications for Seasonal Influenza Market Size by Country in 2024
Figure 55. Germany Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Antiviral Medications for Seasonal Influenza Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Antiviral Medications for Seasonal Influenza Sales Market Share by Region in 2024
Figure 67. Asia Pacific Antiviral Medications for Seasonal Influenza Market Size by Region in 2024
Figure 68. China Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Antiviral Medications for Seasonal Influenza Sales and Growth Rate (K MT)
Figure 79. South America Antiviral Medications for Seasonal Influenza Sales Market Share by Country in 2024
Figure 80. South America Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (M USD)
Figure 81. South America Antiviral Medications for Seasonal Influenza Market Size by Country in 2024
Figure 82. Brazil Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Antiviral Medications for Seasonal Influenza Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Antiviral Medications for Seasonal Influenza Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Antiviral Medications for Seasonal Influenza Market Size by Region in 2024
Figure 92. Saudi Arabia Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Antiviral Medications for Seasonal Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Antiviral Medications for Seasonal Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Antiviral Medications for Seasonal Influenza Production Market Share by Region (2020-2025)
Figure 103. North America Antiviral Medications for Seasonal Influenza Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Antiviral Medications for Seasonal Influenza Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Antiviral Medications for Seasonal Influenza Production (K MT) Growth Rate (2020-2025)
Figure 106. China Antiviral Medications for Seasonal Influenza Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Antiviral Medications for Seasonal Influenza Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Antiviral Medications for Seasonal Influenza Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Antiviral Medications for Seasonal Influenza Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Antiviral Medications for Seasonal Influenza Market Share Forecast by Type (2026-2035)
Figure 111. Global Antiviral Medications for Seasonal Influenza Sales Forecast by Application (2026-2035)
Figure 112. Global Antiviral Medications for Seasonal Influenza Market Share Forecast by Application (2026-2035)
